Correlate each infectious disease scenario with the specific cellular mechanism of its causative bacterial toxin.
- A 7-year-old child with no vaccination history presents with profound weakness and a grayish exudate over the tonsils.Catalyzes ADP-ribosylation of elongation factor-2 to halt cellular protein synthesis
- A 45-year-old man exhibits dysarthria, blurred vision, and symmetric descending weakness after eating home-preserved vegetables.Cleaves SNARE proteins to block acetylcholine release at the neuromuscular junction
- A 32-year-old aid worker develops massive volumes of 'rice-water' diarrhea leading to severe dehydration without fever.Catalyzes ADP-ribosylation of the Gs-alpha subunit to constitutively activate adenylate cyclase
- A 55-year-old farmer experiences severe facial muscle spasms and jaw stiffness days after stepping on a rusty nail.Cleaves SNARE proteins to block the release of GABA and glycine from spinal inhibitory interneurons
- A 22-year-old woman develops a sudden high fever, diffuse macular rash, and hypotension associated with retained nasal packing.Cross-links the T-cell receptor beta chain directly to MHC class II on antigen-presenting cells
Cevap
The correct matches pair each clinical syndrome with the distinct molecular action of its causative bacterial exotoxin: Diphtheria with EF-2 inhibition; Botulism with peripheral SNARE cleavage; Cholera with Gs-alpha activation; Tetanus with central SNARE cleavage; and Toxic Shock Syndrome with MHC-II/TCR cross-linking.
Each pathogen utilizes a distinct exotoxin with a specific molecular target. Diphtheria toxin ADP-ribosylates EF-2. Botulinum toxin cleaves SNARE proteins at the peripheral neuromuscular junction. Cholera toxin ADP-ribosylates Gs-alpha. Tetanus toxin cleaves SNARE proteins in central inhibitory interneurons. TSST-1 acts as a superantigen by cross-linking MHC-II and the T-cell receptor.
Adım Adım Çözüm
Anahtar Kavram
Bacterial exotoxins utilize specific molecular mechanisms, such as ADP-ribosylation, SNARE protein cleavage, and superantigen activity, to disrupt normal host cell function and cause characteristic clinical syndromes.